The safety of antithrombotic therapy during pregnancy

Bibliography

• MACKLON NS, GREER IA: thromboembolic disease in obstetrics and gynaecology: the Scottish experience. Scott. Med. J. (1996) 41:83–86.
   PubMed Web of Science ®Google Scholar
• ATHRASH HK, KOONIN LM, HW, FRANKS AL, SMITH JC: Maternal morbidity in the United States 1979-1986. Obstet. Gynecol (1990) 76:1055–1060.
   PubMed Web of Science ®Google Scholar
• HOGBERG U, INNALA E, A: Maternal mortality in Sweden. Obstet. Gynecol (1995) 84:240–244.
   Web of Science ®Google Scholar
• NO AUTHORS LISTED: on confidential inquiries into maternal deaths in UK 1994–1996: HMSO, London (1998):84.
   Google Scholar
• JAMES K, LOHRJ, DESHMUKH R, CRANLEY JJ: Venous thrombotic complications of pregnancy. Sing. (1996) 4:777–782.
   Google Scholar
• RUTHERFORD S, MONTORO M, MCGEHEE W, STRONG T: Thromboembolic disease associated with pregnancy: an 11 year review. Am. .1 Obstet. Gynecol (1991) 164:286. Abstract.
   Google Scholar
• ELDOR A: The use of low molecular weight heparin for the management of venous thromboembolism in pregnancy. Eur: I Obstet. Gynecol Reprod. Biol. (2002) 104:3–13.
   PubMed Web of Science ®Google Scholar
• •Extensive overview on the use of LMWH in pregnancy.
   Google Scholar
• BAZZAN M, DONVITO V: Low molecular heparin during pregnancy. Thromb. Res. (2001) 101:V175–V186.
   PubMed Web of Science ®Google Scholar
• •Extensive overview on the use of LMWH in pregnancy.
   Google Scholar
• WEG JG: Venous thromboembolism in pregnancy. Semin. Reprod. Crit. Care Med. (1998) 19(3):231–241.
   Web of Science ®Google Scholar
• GINSBERG JS: Thromboembolism in pregnancy. Thromb. Haemost. (1999) 82(2):620–625.
   PubMed Web of Science ®Google Scholar
• •Overview on the risk of VTE and its management in pregnancy.
   Google Scholar
• LOCKWOOD CJ: Heritable coagulopathies in pregnancy. Obstet. Gynecol Surv. (1999) 54(12):754–765.
   PubMedGoogle Scholar
• FRIEDERICH PW, SANSON PJ, SIMIONI P et al.: Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis. Intern. Med. (1996) 125:955–960.
   Web of Science ®Google Scholar
• PRESTON FE, ROSENDAAL F, WALKER ID et al.: Increased fetal loss in women with heritable thrombophilia. Lancet (1996) 348:913–916.
   PubMed Web of Science ®Google Scholar
• GINSBERG JS, BRILL-EDWARDS P, JOHNSTON M et al: Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross sectional study. Blood (1992) 80:975–980.
   PubMed Web of Science ®Google Scholar
• WONG V, CHENG CH, CHAN KC: Fetal neonatal outcome of exposure to anticoagulants during pregnancy. Am. J. Med. Genet. (1993) 45:17–21.
   PubMed Web of Science ®Google Scholar
• •Report on the risks related to warfarin treatment during pregnancy.
   Google Scholar
• ZAKZOUK MS: The congenital warfarin. J. LaryngoL Otol. (1986) 100:215–219.
   PubMed Web of Science ®Google Scholar
• GINSBERG JS, HIRSH J, TURNER CD et al.: Risks to the fetus of anticoagulant therapy during pregnancy. Thromb. Haemost. (1989) 61:197–203.
   PubMed Web of Science ®Google Scholar
• BURNS MM: Emerging concepts in the diagnosis and management of venous thromboembolism during pregnancy. Thromb. Thrombolysis (2000) 10:59–68.
   PubMed Web of Science ®Google Scholar
• ORME LE, LEWIS M, DE SWIET M et al: May mothers given warfarin breast-feed their infants?M: Med. J. (1977) 1:1564–1565.
   Google Scholar
• GINSBERG JS, KOWALCHUK G, HIRSH J et al.: Heparin therapy during pregnancy: risks to the fetus and mother. Arch. Intern. Med. (1989) 149:2233–2236.
   PubMed Web of Science ®Google Scholar
• •Report on the risks related to the use of heparin during pregnancy.
   Google Scholar
• ANDERSON DR, GINSBERG JS, BURROWS R et al.: Subcutaneous heparin therapy during pregnancy: a need for concern at the time of delivery. Thromb. Haemost. (1991) 63:248–250.
   Google Scholar
• WARKENTIN TE, LEVINE MN, HIRSH J et al.: Heparin-induced thrombocytopenia in patients treated with low molecular weight heparin or unfractionated heparin. Engl. I Med. (1995) 332:1330–1335.
   PubMed Web of Science ®Google Scholar
• DOUKETIS JD, GINSBERG JS, BURROWS RF et al.: The effects of long-term heparin therapy during pregnancy on bone density. Thromb. Haemost. (1996) 75:254–257.
   PubMed Web of Science ®Google Scholar
• DAHLMAN TC: Osteoporotic fractures andthe recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am. I Obstet. Gynecol (1993) 168:1265–1270.
   PubMed Web of Science ®Google Scholar
• SANS ON BJ, LENSING AWA, MH et al.: Safety of low molecular weight heparin in pregnancy: a systematic review. Thromb. Haemost. (1999) 81:668–672.
   PubMed Web of Science ®Google Scholar
• SHEFRAS J, FARQUHARSON RG: Bone density studies in pregnant women receiving heparin. Eur. I Obstet. GynecoL (1996) 65:171–174.
   PubMed Web of Science ®Google Scholar
• GILLIS S, SHUSHAN A, ELDOR A: Use of low molecular weight heparin for prophylaxis and treatment of thromboembolism in pregnancy. .1. GynaecoL Obstet. (1992) 39:297–301.
   PubMed Web of Science ®Google Scholar
• MONREAL M, LAFOZ E, OLIVE A, DEL RIO L, VEDIA C: Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. Haernost. (1994) 71:7–11.
   PubMed Web of Science ®Google Scholar
• IMPERIALE TF, PETRULIS AS: A meta-analysis of low dose aspirin for prevention of pregnancy-induced hypertensive disease. JAMA (1991) 266:260–264.
   PubMed Web of Science ®Google Scholar
• •Meta-analysis of studies on the use of aspirin during pregnancy.
   Google Scholar
• NO AUTHORS LISTED:: a randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet (1994) 343:619–629.
   PubMed Web of Science ®Google Scholar
• GINSBERG JS, GREER I, HIRSH J: Use of antithrombotic agents during pregnancy. Chest (2001) 119:S122–S131.
   Google Scholar
• ••Clinical guidelines published after theresults of a consensus conference.
   Google Scholar
• CHANG WS, ANAND S, GINSBERG JS:Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch. Intern. Med. (2000) 160:191–196.
   PubMed Web of Science ®Google Scholar
• •Extensive review of the available evidence on the safety and efficacy of different antithrombotic treatment strategies for pregnant women with mechanical heart valves.
   Google Scholar
• TASK FORCE ON THE MANAGEMENT OF CARDIOVASCULAR DISEASES DURING PREGNANCY OF THE EUROPEAN SOCIETY OF CARDIOLOGY: consensus document on management of cardiovascular diseases during pregnancy. Eur. Heart (2003) 24:761-781. guidelines published by the European Society of Cardiology.
   Google Scholar